Concert Pharmaceuticals, Inc. Net Profit Margin 2014-2022 | CNCE
Concert Pharmaceuticals, Inc. net profit margin from 2014 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2022-09-30 | $0.00B | $-0.13B | inf% |
| 2022-06-30 | $0.00B | $-0.13B | -12500.00% |
| 2021-12-31 | $0.03B | $-0.08B | -245.45% |
| 2021-09-30 | $0.03B | $-0.07B | -203.03% |
| 2021-06-30 | $0.03B | $-0.06B | -173.53% |
| 2021-03-31 | $0.01B | $-0.08B | -962.50% |
| 2020-12-31 | $0.01B | $-0.07B | -925.00% |
| 2020-09-30 | $0.01B | $-0.07B | -900.00% |
| 2020-06-30 | $0.01B | $-0.07B | -1166.67% |
| 2020-03-31 | $0.00B | $-0.08B | inf% |
| 2019-12-31 | $0.00B | $-0.08B | -7800.00% |
| 2019-09-30 | $0.00B | $-0.08B | -7900.00% |
| 2019-06-30 | $0.00B | $-0.08B | -7900.00% |
| 2019-03-31 | $0.00B | $-0.07B | -7300.00% |
| 2018-12-31 | $0.01B | $-0.06B | -550.00% |
| 2018-09-30 | $0.01B | $-0.04B | -400.00% |
| 2018-06-30 | $0.15B | $0.10B | 67.53% |
| 2018-03-31 | $0.15B | $0.10B | 67.53% |
| 2017-12-31 | $0.14B | $0.10B | 65.97% |
| 2017-09-30 | $0.14B | $0.09B | 61.81% |
| 2017-06-30 | $0.00B | $-0.05B | inf% |
| 2017-03-31 | $0.00B | $-0.05B | inf% |
| 2016-12-31 | $0.00B | $-0.05B | inf% |
| 2016-09-30 | $0.01B | $-0.04B | -370.00% |
| 2016-06-30 | $0.01B | $-0.04B | -291.67% |
| 2016-03-31 | $0.07B | $0.02B | 29.23% |
| 2015-12-31 | $0.07B | $0.02B | 36.36% |
| 2015-09-30 | $0.06B | $0.01B | 24.56% |
| 2015-06-30 | $0.06B | $0.02B | 25.42% |
| 2015-03-31 | $0.01B | $-0.03B | -485.71% |
| 2014-12-31 | $0.01B | $-0.03B | -400.00% |
| 2014-09-30 | $0.01B | $-0.02B | -250.00% |
| 2014-06-30 | $0.01B | $-0.02B | -380.00% |
| 2014-03-31 | $0.02B | $-0.01B | -52.38% |
| 2013-12-31 | $0.03B | $-0.01B | -24.00% |
